Literature DB >> 7359682

Hypernatremia in hepatic failure.

S E Warren, J A Mitas, A H Swerdlin.   

Abstract

The presence of hypernatremia in patients with hepatic failure has not received major attention. We examined the records of 25 patients admitted to the hospital with decompensated liver disease (usually Laënnec's cirrhosis) and found hypernatremia in 15. Probable causes include increased insensible water losses, impairment of water intake due to encephalopathy, and the use of osmotic cathartics with hypotonic enteric losses. Patients in this series showing hypernatremia had a mortality of 87%. Mortality in those without hypernatremia was 60%. The presence of increased serum sodium concentrations in patients with decompensated liver disease is an ominous but correctable abnormality reflecting a disturbance in water balance.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7359682

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  8 in total

1.  Diffuse demyelinating lesions of the brain after the rapid development of hypernatremia.

Authors:  W R Clark
Journal:  West J Med       Date:  1992-11

2.  Effect of the pretransplant serum sodium concentration on outcomes following liver transplantation.

Authors:  Michael D Leise; Byung Cheol Yun; Joseph J Larson; Joanne T Benson; Ju Dong Yang; Terry M Therneau; Charles B Rosen; Julie K Heimbach; Scott W Biggins; W Ray Kim
Journal:  Liver Transpl       Date:  2014-06       Impact factor: 5.799

3.  Hyponatremia Is Associated With Increased Mortality in Children on the Waiting List for Liver Transplantation.

Authors:  Dmitri Bezinover; Lauren Nahouraii; Alexandr Sviatchenko; Ming Wang; Steven Kimatian; Fuat H Saner; Jonathan G Stine
Journal:  Transplant Direct       Date:  2020-09-17

4.  Association of serum sodium with morbidity and mortality in hospitalized patients undergoing major orthopedic surgery.

Authors:  Finnian R Mc Causland; John Wright; Sushrut S Waikar
Journal:  J Hosp Med       Date:  2014-02-13       Impact factor: 2.960

Review 5.  Preventing neurological complications from dysnatremias in children.

Authors:  Michael L Moritz; J Carlos Ayus
Journal:  Pediatr Nephrol       Date:  2005-08-04       Impact factor: 3.714

6.  Comparison of rifaximin and lactulose for the treatment of hepatic encephalopathy: a prospective randomized study.

Authors:  Yong Han Paik; Kwan Sik Lee; Kwang Hyub Han; Kun Hoon Song; Myoung Hwan Kim; Byung Soo Moon; Sang Hoon Ahn; Se Joon Lee; Hyo Jin Park; Dong Ki Lee; Chae Yoon Chon; Sang In Lee; Young Myoung Moon
Journal:  Yonsei Med J       Date:  2005-06-30       Impact factor: 2.759

7.  AKI in patients with acute on chronic liver failure is different from acute decompensation of cirrhosis.

Authors:  Rakhi Maiwall; Suman Kumar; Shivendra Singh Chandel; Guresh Kumar; Archana Rastogi; Chhagan Bihari; Manoj Kumar Sharma; Bhaskar Thakur; K Jamwal; Suman Nayak; R P Mathur; S K Sarin
Journal:  Hepatol Int       Date:  2015-09-02       Impact factor: 6.047

Review 8.  Approach and management of dysnatremias in cirrhosis.

Authors:  Mauro Bernardi; Giacomo Zaccherini
Journal:  Hepatol Int       Date:  2018-09-10       Impact factor: 6.047

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.